Four Contrast Media Giants Share a EUR 56.5 Million Italian Hospital Injector Rental Contract

Standfirst

ASST Ovest Milanese, leading an aggregated tender on behalf of a group of Lombardy health authorities, has awarded a six-year, EUR 56 543 560 framework for rental of contrast media injection systems and consumables across radiology, cardiology, CT and MRI applications. Guerbet, Bayer, Bracco Imaging and Performance Hospital share the largest lots, with specialist supplier Biover taking the cardiology category alone.

Introduction

Every CT scan or MRI that relies on contrast dye depends on a piece of equipment most patients never think about: the injector system that delivers the contrast media at a precisely controlled rate. Lombardy's ASST Ovest Milanese has coordinated a large scale, six year procurement to secure this equipment, along with the syringes and contrast media consumables that go with it, on behalf of a group of regional health authorities.

Rather than a single winner, the tender split into four clinical application categories, interventional radiology, cardiology, CT and MRI, drawing in the world's major contrast media manufacturers, Guerbet, Bayer and Bracco Imaging, alongside specialist injector and equipment suppliers Biover and Performance Hospital.

Why This Contract Matters

Contrast media injector systems sit at the intersection of medical device and pharmaceutical supply, since the equipment itself is typically provided on a rental basis while the real recurring cost comes from the contrast media and disposable consumables used with each patient scan. Structuring this as a rental plus consumables framework, rather than an outright equipment purchase, lets the participating hospitals avoid large upfront capital costs while securing guaranteed consumable supply for six years.

The tender's aggregated structure, run by ASST Ovest Milanese on behalf of a wider group of Lombardy health authorities, also reflects a broader trend in Italian regional healthcare procurement toward pooling purchasing power across multiple hospital trusts rather than each authority tendering separately.

Contract Timeline

• Procedure type: Open procedure under Directive 2014/24/EU
• Notice dispatched to the Publications Office: 27 August 2026
• Published in the Official Journal, OJ S 166/2026: 28 August 2026
• Contract duration: 72 months (6 years), all lots

Contract Overview

ASST Ovest Milanese ran a multi-lot open procedure under Italy's 2023 procurement code to conclude a framework agreement for rental supply of contrast media injection systems and related consumables, on behalf of an aggregated group of health authorities, split into four lots by clinical application. The combined estimated and maximum framework value across all four lots is EUR 56 543 560. Each lot was awarded on a quality and price basis, quality weighted at 70 percent and price at 30 percent and structured as a framework agreement without reopening of competition.

Key Contract Details

Project Scope

The four lots divide contrast media injector systems and their consumables by clinical use: Lot 1 covers systems for interventional radiology, Lot 2 covers systems for cardiology diagnostics, Lot 3 covers systems for computed tomography and Lot 4 covers systems for magnetic resonance imaging. In each case, the winning suppliers provide the injector equipment on a rental basis alongside the associated consumable materials, including contrast media and delivery components, needed for the equipment's ongoing clinical use across the six year contract term.

About the Contracting Authority

ASST Ovest Milanese is a public undertaking active in the health sector, based in the Milan area of Lombardy. It served as the lead authority, or capofila, coordinating this aggregated tender on behalf of a wider group of Lombardy health authorities, a common structure in Italian regional healthcare procurement that lets multiple hospital trusts benefit from combined purchasing volume and a single centrally run tender process.

About the Organisations Involved

ASST Ovest Milanese

As covered above, ASST Ovest Milanese is the lead buyer running this aggregated tender on behalf of the participating health authorities.

TAR Milano

The Regional Administrative Court of Milan is named as the review organisation for this contract, the standard venue for procurement disputes involving Lombardy health authorities.

Guerbet

Guerbet, based in Milan, is one of the world's leading contrast media manufacturers and won places across three of the four lots: Lot 1 (interventional radiology), Lot 3 (CT) and Lot 4, alongside Bayer and Bracco Imaging in that latter category, giving it the broadest presence among the winning suppliers.

Biover Srl

Biover Srl, based in the Como area, won Lot 2, the cardiology diagnostics category, as the sole supplier for that lot.

Bayer S.p.A.

Bayer S.p.A., based in Milan, is the Italian arm of the global pharmaceutical and life sciences group and won places in both Lot 3 (CT) and Lot 4 (MRI), reflecting its established position as a major supplier of contrast media used in these imaging modalities.

Bracco Imaging S.p.A.

Bracco Imaging S.p.A., based in Milan, is a major global diagnostic imaging and contrast media company and won places in both Lot 3 and Lot 4 alongside Guerbet and Bayer.

Performance Hospital Srl

Performance Hospital Srl, based in the Bergamo area, won places in both Lot 3 and Lot 4, rounding out the group of suppliers sharing the CT and MRI contrast media injection categories.

Procurement Analysis

Award criteria weighted quality heavily across all four lots, at 70 percent against 30 percent for price, a structure that prioritises clinical performance and equipment reliability over simple cost minimisation, appropriate for equipment directly involved in patient diagnostic imaging. The multi-supplier structure for Lots 3 and 4, each shared among several major contrast media manufacturers, gives the participating hospitals choice among suppliers for the largest, highest volume imaging categories, CT and MRI, while the smaller, more specialised radiology and cardiology lots each went to a single supplier.

The combined lot estimated values sum exactly to the procedure's overall EUR 56 543 560 figure, a clean, internally consistent notice with no unexplained discrepancy between the different value fields.

Additional Procurement Facts

• None of the four lots are financed with EU funds.
• All four lots are confirmed as covered by the Government Procurement Agreement.
• Detailed award criteria weighting methodology is deferred to the tender's own specifications document, referenced but not reproduced in this notice.

Market and Industry Perspective

This award brings together virtually the full roster of major global contrast media manufacturers competing directly for Italian public hospital business, with Guerbet, Bayer and Bracco Imaging each securing multiple lot positions. That concentration reflects how few companies operate at the scale needed to supply contrast media and injector systems across an aggregated regional tender of this size, while smaller specialist suppliers like Biover and Performance Hospital still found room to compete successfully in specific categories.

Economic Significance

At EUR 56 543 560 over six years, this is a substantial, recurring commitment for Lombardy's aggregated health authority group, securing both equipment access and consumable supply for diagnostic imaging services that underpin a wide range of clinical care across the region's hospitals.

Future Procurement Opportunities

With a fixed 72 month term and no framework reopening mechanism, this contract will need to be retendered in full once its term concludes, likely around 2032, offering other contrast media and injector equipment suppliers a future opportunity to compete for this aggregated regional business.

Opportunities for Suppliers

Contrast media manufacturers and injector equipment specialists should note the aggregated tender model demonstrated here as an increasingly common structure in Italian regional healthcare procurement, where competing for a single, well organised tender can secure access to a considerably larger customer base than negotiating with individual hospital trusts separately.

What Businesses Should Watch

• How the participating health authorities allocate call-offs among the multiple winning suppliers in the CT and MRI categories.
• Further aggregated tenders from ASST Ovest Milanese or other Lombardy health authority groups for related diagnostic imaging equipment.
• Broader consolidation trends in Italian regional healthcare procurement toward aggregated, multi-authority tenders.

ItalyTenders.com Procurement Intelligence

This contract illustrates how Italian regional healthcare procurement increasingly favours aggregated tenders that pool purchasing power across multiple hospital trusts, giving both buyers and suppliers a more efficient single process rather than fragmented, authority by authority competitions. For contrast media and imaging equipment manufacturers, competing successfully in this kind of aggregated tender offers access to a considerably larger and more stable customer base than individual hospital contracts would provide.

The multi-supplier structure for the largest lots, CT and MRI, also reflects a sensible approach to managing supply risk in a category, contrast media, where clinical preference and patient-specific factors can matter as much as pure cost, giving hospitals flexibility to choose among several qualified suppliers rather than being locked into one.

Supplier Takeaways

• This aggregated tender drew in nearly every major global contrast media manufacturer, confirming the value of competing for pooled regional healthcare contracts in Italy.
• Award criteria weighted quality at 70 percent across all lots, prioritising clinical performance over price alone.
• Multi-supplier lot structures for the largest categories give hospitals ongoing supplier choice rather than single-vendor lock-in.
• Specialist equipment suppliers can still win standalone categories, as Biover's sole win of the cardiology lot demonstrates.
• This six year framework will need a full recompete around 2032, offering a predictable future opportunity for the market.

Key Takeaways

• ASST Ovest Milanese led an aggregated tender awarding a EUR 56 543 560, six-year framework for contrast media injection systems and consumables across four clinical application lots.
• Guerbet won Lot 1 alone and shares Lots 3 and 4 with Bayer, Bracco Imaging and Performance Hospital.
• Biover Srl won Lot 2, the cardiology diagnostics category, as the sole supplier.
• Award criteria weighted quality at 70 percent and price at 30 percent across all lots.
• The contract is not financed with EU funds and is covered by the Government Procurement Agreement.
• The combined lot values reconcile exactly with the procedure's overall estimated value, with no unexplained discrepancy.

Conclusion

Behind every contrast enhanced scan a Lombardy hospital performs over the next six years sits this carefully structured, aggregated procurement, bringing together the world's leading contrast media manufacturers under a single regional framework. For the participating health authorities, it is a coordinated way to secure both equipment and consumables at scale. For the winning suppliers, it is a substantial, multi-year foothold across one of Italy's largest healthcare markets.

Source: Tenders Electronic Daily (TED), Contract Award Notice 594049-2026, Official Journal of the European Union, OJ S 166/2026, published on 28 August 2026.